The Impact of HIV and Parasite Single Infection and Coinfection on Telomere Length: A Systematic Review

Autor: Engelinah D. Macamo, Zilungile L. Mkhize-Kwitshana, Julian Mthombeni, Pragalathan Naidoo

Publikováno v: Current Issues in Molecular Biology, Vol 46, Iss 7, Pp 7258-7290 (2024)

HIV and parasite infections accelerate biological aging, resulting in immune senescence, apoptosis and cellular damage. Telomere length is considered to be one of the most effective biomarkers of biological aging. HIV and parasite infection have been

Externí odkaz: https://doaj.org/article/ed69895416034213bb32ba5ab3426df7

Microbiota, Fiber, and NAFLD: Is There Any Connection?

Autor: Pérez-Montes de Oca A, Julián MT, Ramos A, Puig-Domingo M, Alonso N

Publikováno v: Nutrients
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP: Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)

Gut microbiota can contribute to the development and progression of non-alcoholic fatty liver disease (NAFLD). In fact, some specific changes of gut microbiota are observed in patients in what is called dysbiota. There has been a lot of investigation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::da73ff5e321c03aa3e527b20e8178ea6
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1374

Therapeutic implications for sphingolipid metabolism in metabolic dysfunction-associated steatohepatitis.

Autor: Ramos-Molina B; Group of Obesity, Diabetes & Metabolism, Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain., Rossell J; Group of Endocrinology, Diabetes & Nutrition, Institut de Recerca SANT PAU, Barcelona, Spain.; Centro de Investigación Biomédica en Red (CIBER) de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Madrid, Spain., Pérez-Montes de Oca A; Department of Endocrinology & Nutrition, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Pardina E; Department de Biochemistry & Molecular Biology, Facultat de Biologia, Universitat de Barcelona (UB), Barcelona, Spain., Genua I; Department of Endocrinology & Nutrition, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Rojo-López MI; Group of Endocrinology, Diabetes & Nutrition, Institut de Recerca SANT PAU, Barcelona, Spain., Julián MT; Department of Endocrinology & Nutrition, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Alonso N; Centro de Investigación Biomédica en Red (CIBER) de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Madrid, Spain.; Department of Endocrinology & Nutrition, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Julve J; Group of Endocrinology, Diabetes & Nutrition, Institut de Recerca SANT PAU, Barcelona, Spain.; Centro de Investigación Biomédica en Red (CIBER) de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Madrid, Spain., Mauricio D; Group of Endocrinology, Diabetes & Nutrition, Institut de Recerca SANT PAU, Barcelona, Spain.; Centro de Investigación Biomédica en Red (CIBER) de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Madrid, Spain.; Department of Endocrinology & Nutrition, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Department of Endocrinology & Nutrition, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Faculty of Medicine, University of Vic/Central University of Catalonia (UVIC/UCC), Vic, Spain.

Publikováno v: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Jun 19; Vol. 15, pp. 1400961. Date of Electronic Publication: 2024 Jun 19 (Print Publication: 2024).

The double burden: type 1 diabetes and heart failure-a comprehensive review.

Autor: Julián MT; Department of Endocrinology and Nutrition, Hospital Germans Trias i Pujol, Badalona, Spain. mtjulian.germanstrias@gencat.cat.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain. mtjulian.germanstrias@gencat.cat., Pérez-Montes de Oca A; Department of Endocrinology and Nutrition, Hospital Germans Trias i Pujol, Badalona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Julve J; Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain.; Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain., Alonso N; Department of Endocrinology and Nutrition, Hospital Germans Trias i Pujol, Badalona, Spain. nalonso32416@yahoo.es.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain. nalonso32416@yahoo.es.; Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain. nalonso32416@yahoo.es.

Publikováno v: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Feb 12; Vol. 23 (1), pp. 65. Date of Electronic Publication: 2024 Feb 12.

Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: A population-based study.

Autor: Julián MT; Department of Endocrinology and Nutrition, Hospital Universitario Germans Trias I Pujol, Badalona, Barcelona, Spain., Ballesta S; Department of Endocrinology and Nutrition, Hospital Universitario Germans Trias I Pujol, Badalona, Barcelona, Spain., Pera G; Unitat de Suport a la Recerca (USR) Metropolitana Nord, Fundació Institut Universitari d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAP Jordi Gol), Mataró, Spain., Pérez-Montes de Oca A; Department of Endocrinology and Nutrition, Hospital Universitario Germans Trias I Pujol, Badalona, Barcelona, Spain., Soldevila B; Department of Endocrinology and Nutrition, Hospital Universitario Germans Trias I Pujol, Badalona, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Caballería L; Unitat de Suport a la Recerca (USR) Metropolitana Nord, Fundació Institut Universitari d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAP Jordi Gol), Mataró, Spain.; Centro d'Investigaciones Biomédicas en Red, Enfermedades Hepatologia y Digestivas, Barcelona, Spain., Morillas R; Centro d'Investigaciones Biomédicas en Red, Enfermedades Hepatologia y Digestivas, Barcelona, Spain.; Hepatology Department, Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain., Expósito C; Unitat de Suport a la Recerca (USR) Metropolitana Nord, Fundació Institut Universitari d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAP Jordi Gol), Mataró, Spain.; Centro d'Investigaciones Biomédicas en Red, Enfermedades Hepatologia y Digestivas, Barcelona, Spain., Martínez-Escudé A; Unitat de Suport a la Recerca (USR) Metropolitana Nord, Fundació Institut Universitari d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAP Jordi Gol), Mataró, Spain.; Primary Care, Centre d'Atenció Primària La Llagosta, Institut Català de la Salut, Barcelona, Spain., Puig-Domingo M; Department of Endocrinology and Nutrition, Hospital Universitario Germans Trias I Pujol, Badalona, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center for Biomedical Research on Diabetes and Associated Metabolic diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain., Franch-Nadal J; Center for Biomedical Research on Diabetes and Associated Metabolic diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.; Primary Health Care Center Raval Sud, Gerència d'Atenció Primaria, Institut Català de la Salut, Barcelona, Spain., Torán P; Unitat de Suport a la Recerca (USR) Metropolitana Nord, Fundació Institut Universitari d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAP Jordi Gol), Mataró, Spain.; Centro d'Investigaciones Biomédicas en Red, Enfermedades Hepatologia y Digestivas, Barcelona, Spain., Cusi K; Division of Endocrinology, Diabetes and Metabolism. University of Florida, Gainesville, FL, United States., Julve J; Center for Biomedical Research on Diabetes and Associated Metabolic diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.; Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau; Institut d'Investigació Biomédica Sant Pau (IIB Sant Pau), Barcelona, Spain.; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Barcelona, Spain., Mauricio D; Center for Biomedical Research on Diabetes and Associated Metabolic diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.; Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau; Institut d'Investigació Biomédica Sant Pau (IIB Sant Pau), Barcelona, Spain.; Faculty of Medicine, University of Vic, Central University of Catalonia, Vic, Spain., Alonso N; Department of Endocrinology and Nutrition, Hospital Universitario Germans Trias I Pujol, Badalona, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center for Biomedical Research on Diabetes and Associated Metabolic diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.

Publikováno v: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Jan 13; Vol. 13, pp. 1051958. Date of Electronic Publication: 2023 Jan 13 (Print Publication: 2022).